⚡USFDA Grants Final Approval to Cipla for Lanreotide Injection To Treat Tumours
By IANS
Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs).